BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36573573)

  • 1. Consultative meeting to review progress in introducing seasonal influenza vaccination in the Eastern Mediterranean Region.
    East Mediterr Health J; 2022 Dec; 28(12):917-918. PubMed ID: 36573573
    [No Abstract]   [Full Text] [Related]  

  • 2. Consultative meeting to discuss ways to promote the use of seasonal influenza vaccine among high-risk groups in the Eastern Mediterranean Region.
    East Mediterr Health J; 2021 Jan; 27(1):96-97. PubMed ID: 33538325
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a road map to scale up the uptake and utilization of influenza vaccine in 22 countries of Eastern Mediterranean Region.
    Chughtai AA; Mohammed S; Al Ariqi L; McCarron M; Bresee J; Abubakar A; Khan W
    Vaccine; 2022 Oct; 40(45):6558-6565. PubMed ID: 36208976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11-14 December, 2017, Amman, Jordan.
    Abubakar A; Barakat A; Ahmed A; El Kholy A; Alsawalh L; Al Ariqi L; Rahman Malik M; Obtel M; Sahak M; Mrad P; Triki S; Al Awaidy S; Khan WM
    J Infect Public Health; 2020 Mar; 13(3):451-456. PubMed ID: 32144017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of policies and coverage of seasonal influenza vaccination programs in the WHO Eastern Mediterranean Region.
    Attia R; Abubakar A; Bresee J; Mere O; Khan W
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13126. PubMed ID: 36970569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward.
    Abubakar A; Melhem N; Malik M; Dbaibo G; Khan WM; Zaraket H
    Vaccine; 2019 Mar; 37(12):1601-1607. PubMed ID: 30795940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of seasonal influenza vaccination in the Eastern Mediterranean Region: Policies, use and barriers.
    Zaraket H; Melhem N; Malik M; Khan WM; Dbaibo G; Abubakar A
    J Infect Public Health; 2020 Mar; 13(3):377-384. PubMed ID: 32146138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic influenza preparedness (PIP) framework: Progress challenges in improving influenza preparedness response capacities in the Eastern Mediterranean Region, 2014-2017.
    Abubakar A; Elkholy A; Barakat A; Shrestha B; Elhakim M; Malik MR; Bergeri I; Samaan G
    J Infect Public Health; 2020 Mar; 13(3):446-450. PubMed ID: 30905541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of seasonal influenza vaccination in the Eastern Mediterranean Region: Policies, use and barriers.
    Zaraket H; Melhem N; Malik M; Khan WM; Dbaibo G; Abubakar A
    J Infect Public Health; 2019; 12(4):472-478. PubMed ID: 30446255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11-14 December, 2017, Amman, Jordan.
    Abubakar A; Barakat A; Ahmed A; El Kholy A; Alsawalh L; Al Ariqi L; Malik MR; Obtel M; Sahak M; Mrad P; Triki S; Al Awaidy S; Khan WM
    J Infect Public Health; 2019; 12(4):534-539. PubMed ID: 30733047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved capacity for influenza surveillance in the WHO Eastern Mediterranean Region: Progress in a challenging setting.
    Malik MR; Abubakar A; Kholy AE; Buliva E; Khan WM; Lamichhane J; Moen A; McCarron M; Zureick K; Obtel M
    J Infect Public Health; 2020 Mar; 13(3):391-401. PubMed ID: 31522968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of laboratories in the WHO Eastern Mediterranean Region to the selection of candidate seasonal influenza vaccine, 2010-2015.
    Asghar H; Browne HM; McCauley J; Malik M; Khan W
    East Mediterr Health J; 2016 Oct; 22(7):445-452. PubMed ID: 27714738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the power of advocacy to improve seasonal influenza vaccination coverage in the Eastern Mediterranean Region.
    Zaraketa H; Abubakar A
    East Mediterr Health J; 2020 Feb; 26(2):138-140. PubMed ID: 32141589
    [No Abstract]   [Full Text] [Related]  

  • 14. A global review of seasonal influenza vaccine introduction: analysis of the WHO/UNICEF Joint Reporting Form.
    Sambala EZ; Ngcobo N; Machingaidze S; Wiyeh AB; Mahasha PW; Jaca A; Cooper S; Wiysonge CS
    Expert Rev Vaccines; 2019 Aug; 18(8):859-865. PubMed ID: 31318303
    [No Abstract]   [Full Text] [Related]  

  • 15. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
    Jorgensen P; Mereckiene J; Cotter S; Johansen K; Tsolova S; Brown C
    Vaccine; 2018 Jan; 36(4):442-452. PubMed ID: 29287683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.
    Cowling BJ; Caini S; Chotpitayasunondh T; Djauzi S; Gatchalian SR; Huang QS; Koul PA; Lee PI; Muttalif AR; Plotkin S;
    Vaccine; 2017 Feb; 35(6):856-864. PubMed ID: 28081970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in influenza vaccination coverage in Portugal from 1998 to 2010: effect of major pandemic threats.
    Pinto CS; Nunes B; Branco MJ; Falcão JM
    BMC Public Health; 2013 Dec; 13():1130. PubMed ID: 24314008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on: "Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): Little progress in estimated global vaccination coverage".
    Salisbury DM
    Vaccine; 2016 Jan; 34(4):401-402. PubMed ID: 26707215
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
    Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.